pd 173074 has been researched along with Adenocarcinoma of Lung in 3 studies
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lung cancer is the leading cause of cancer-related deaths across the world." | 1.46 | Drug-sensitive FGFR3 mutations in lung adenocarcinoma. ( Aich, J; Chandna, P; Chandrani, P; Chaudhari, P; Choughule, A; Dhamne, H; Dutt, A; Ingle, A; Iyer, DN; Iyer, P; Joshi, A; Karpe, A; Kumar, R; Mohanty, B; Noronha, V; Patil, V; Prabhash, K; Prasad, R; Ramaswamy, A; Ranjan, M; Sethunath, V; Thorat, R; Upadhyay, P, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandrani, P | 1 |
| Prabhash, K | 1 |
| Prasad, R | 1 |
| Sethunath, V | 1 |
| Ranjan, M | 1 |
| Iyer, P | 1 |
| Aich, J | 1 |
| Dhamne, H | 1 |
| Iyer, DN | 1 |
| Upadhyay, P | 1 |
| Mohanty, B | 1 |
| Chandna, P | 1 |
| Kumar, R | 1 |
| Joshi, A | 1 |
| Noronha, V | 1 |
| Patil, V | 1 |
| Ramaswamy, A | 1 |
| Karpe, A | 1 |
| Thorat, R | 1 |
| Chaudhari, P | 1 |
| Ingle, A | 1 |
| Choughule, A | 1 |
| Dutt, A | 1 |
| Turner, NC | 1 |
| Seckl, MJ | 1 |
| Weiss, J | 1 |
| Sos, ML | 1 |
| Seidel, D | 1 |
| Peifer, M | 1 |
| Zander, T | 1 |
| Heuckmann, JM | 1 |
| Ullrich, RT | 1 |
| Menon, R | 1 |
| Maier, S | 1 |
| Soltermann, A | 1 |
| Moch, H | 1 |
| Wagener, P | 1 |
| Fischer, F | 1 |
| Heynck, S | 1 |
| Koker, M | 1 |
| Schöttle, J | 1 |
| Leenders, F | 1 |
| Gabler, F | 1 |
| Dabow, I | 1 |
| Querings, S | 1 |
| Heukamp, LC | 1 |
| Balke-Want, H | 1 |
| Ansén, S | 1 |
| Rauh, D | 1 |
| Baessmann, I | 1 |
| Altmüller, J | 1 |
| Wainer, Z | 1 |
| Conron, M | 1 |
| Wright, G | 1 |
| Russell, P | 1 |
| Solomon, B | 1 |
| Brambilla, E | 1 |
| Brambilla, C | 1 |
| Lorimier, P | 1 |
| Sollberg, S | 1 |
| Brustugun, OT | 1 |
| Engel-Riedel, W | 1 |
| Ludwig, C | 1 |
| Petersen, I | 1 |
| Sänger, J | 1 |
| Clement, J | 1 |
| Groen, H | 1 |
| Timens, W | 1 |
| Sietsma, H | 1 |
| Thunnissen, E | 1 |
| Smit, E | 1 |
| Heideman, D | 1 |
| Cappuzzo, F | 1 |
| Ligorio, C | 1 |
| Damiani, S | 1 |
| Hallek, M | 1 |
| Beroukhim, R | 1 |
| Pao, W | 1 |
| Klebl, B | 1 |
| Baumann, M | 1 |
| Buettner, R | 1 |
| Ernestus, K | 1 |
| Stoelben, E | 1 |
| Wolf, J | 1 |
| Nürnberg, P | 1 |
| Perner, S | 1 |
| Thomas, RK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study on Fluids Associated to Lung Cancer, of the Ectopic Expression of Cancer Testis Gene and Mutation as Diagnostics and Prognosis Biomarkers[NCT02853006] | 31 participants (Actual) | Interventional | 2015-06-30 | Completed | |||
| A Prospective Randomized Phase Ⅱ Study of Nimotuzumab Combined With Chemoradiotherapy for Unresectable, Locally Advanced Squamous Cell Lung Cancer[NCT02577341] | Phase 2 | 122 participants (Actual) | Interventional | 2015-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for pd 173074 and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Drug-sensitive FGFR3 mutations in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Animals; Cell Proliferation; Drug Resistance, N | 2017 |
A therapeutic target for smoking-associated lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Blotting, Western; Carcinoma, Non-Small- | 2010 |
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Blotting, Western; Carcinoma, Non-Small- | 2010 |
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Blotting, Western; Carcinoma, Non-Small- | 2010 |
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Blotting, Western; Carcinoma, Non-Small- | 2010 |
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Blotting, Western; Carcinoma, Non-Small- | 2010 |